Ridziauskas, M.; Zablockienė, B.; Jančorienė, L.; Samuilis, A.; Zablockis, R.; Jackevičiūtė, A.
Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs. Medicina 2021, 57, 210.
https://doi.org/10.3390/medicina57030210
AMA Style
Ridziauskas M, Zablockienė B, Jančorienė L, Samuilis A, Zablockis R, Jackevičiūtė A.
Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs. Medicina. 2021; 57(3):210.
https://doi.org/10.3390/medicina57030210
Chicago/Turabian Style
Ridziauskas, Martynas, Birutė Zablockienė, Ligita Jančorienė, Artūras Samuilis, Rolandas Zablockis, and Aušrinė Jackevičiūtė.
2021. "Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs" Medicina 57, no. 3: 210.
https://doi.org/10.3390/medicina57030210
APA Style
Ridziauskas, M., Zablockienė, B., Jančorienė, L., Samuilis, A., Zablockis, R., & Jackevičiūtė, A.
(2021). Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs. Medicina, 57(3), 210.
https://doi.org/10.3390/medicina57030210
